A detailed history of Sage Capital Advisors,Llc transactions in Johnson & Johnson stock. As of the latest transaction made, Sage Capital Advisors,Llc holds 43,501 shares of JNJ stock, worth $6.75 Million. This represents 1.89% of its overall portfolio holdings.

Number of Shares
43,501
Previous 42,785 1.67%
Holding current value
$6.75 Million
Previous $6.25 Million 12.73%
% of portfolio
1.89%
Previous 1.82%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$145.48 - $167.38 $104,163 - $119,844
716 Added 1.67%
43,501 $7.05 Million
Q2 2024

Jul 09, 2024

BUY
$144.38 - $157.78 $42,158 - $46,071
292 Added 0.69%
42,785 $6.25 Million
Q1 2024

Apr 15, 2024

BUY
$155.22 - $162.74 $116,415 - $122,055
750 Added 1.8%
42,493 $6.72 Million
Q4 2023

Jan 09, 2024

BUY
$145.6 - $158.88 $46,155 - $50,364
317 Added 0.77%
41,743 $6.54 Million
Q3 2023

Oct 12, 2023

BUY
$155.75 - $174.48 $41,429 - $46,411
266 Added 0.65%
41,426 $6.45 Million
Q2 2023

Jul 12, 2023

BUY
$154.35 - $166.11 $325,832 - $350,658
2,111 Added 5.41%
41,160 $6.81 Million
Q1 2023

Apr 11, 2023

BUY
$151.05 - $180.26 $402,095 - $479,852
2,662 Added 7.32%
39,049 $6.05 Million
Q4 2022

Jan 19, 2023

BUY
$160.2 - $179.79 $394,732 - $443,002
2,464 Added 7.26%
36,387 $0
Q3 2022

Oct 17, 2022

BUY
$161.33 - $179.52 $363,799 - $404,817
2,255 Added 7.12%
33,923 $5.54 Million
Q2 2022

Jul 06, 2022

BUY
$168.19 - $186.01 $7,736 - $8,556
46 Added 0.15%
31,668 $5.62 Million
Q1 2022

Apr 11, 2022

BUY
$158.14 - $179.59 $42,065 - $47,770
266 Added 0.85%
31,622 $5.76 Million
Q4 2021

Jan 20, 2022

BUY
$155.93 - $173.01 $585,205 - $649,306
3,753 Added 13.6%
31,356 $5.22 Million
Q3 2021

Oct 26, 2021

SELL
$161.5 - $179.47 $55,394 - $61,558
-343 Reduced 1.23%
27,603 $4.46 Million
Q2 2021

Jul 22, 2021

BUY
$159.48 - $171.07 $169,686 - $182,018
1,064 Added 3.96%
27,946 $4.74 Million
Q1 2021

May 04, 2021

SELL
$153.07 - $170.48 $7,959 - $8,864
-52 Reduced 0.19%
26,882 $4.42 Million
Q4 2020

Feb 08, 2021

BUY
$137.11 - $157.38 $959 - $1,101
7 Added 0.03%
26,934 $4.36 Million
Q3 2020

Oct 29, 2020

SELL
$140.38 - $153.83 $9,405 - $10,306
-67 Reduced 0.25%
26,927 $4.01 Million
Q2 2020

Jul 13, 2020

SELL
$128.81 - $155.51 $6,698 - $8,086
-52 Reduced 0.19%
26,994 $3.8 Million
Q1 2020

Apr 17, 2020

BUY
$111.14 - $153.99 $82,021 - $113,644
738 Added 2.81%
27,046 $3.55 Million
Q4 2019

Jan 16, 2020

BUY
$127.5 - $146.44 $18,615 - $21,380
146 Added 0.56%
26,308 $3.84 Million
Q3 2019

Oct 17, 2019

SELL
$126.95 - $142.14 $278,909 - $312,281
-2,197 Reduced 7.75%
26,162 $3.39 Million
Q2 2019

Jul 31, 2019

SELL
$131.15 - $144.24 $1.31 Million - $1.44 Million
-10,014 Reduced 26.1%
28,359 $3.75 Million
Q1 2019

Jul 31, 2019

SELL
$125.72 - $139.79 $1.12 Million - $1.24 Million
-8,906 Reduced 18.84%
38,373 $5.36 Million
Q1 2019

Apr 23, 2019

BUY
$125.72 - $139.79 $1.11 Million - $1.24 Million
8,856 Added 23.05%
47,279 $6.61 Million
Q4 2018

Jul 31, 2019

SELL
$122.84 - $147.84 $1.09 Million - $1.32 Million
-8,906 Reduced 18.82%
38,423 $4.96 Million
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $107,485 - $129,360
875 Added 1.88%
47,329 $6.11 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $28,814 - $33,862
237 Added 0.51%
46,454 $6.42 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $1,552 - $1,712
-13 Reduced 0.03%
46,217 $5.61 Million
Q1 2018

May 01, 2018

BUY
$125.1 - $148.14 $8,381 - $9,925
67 Added 0.15%
46,230 $5.92 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $11,809 - $12,925
90 Added 0.2%
46,163 $6.45 Million
Q3 2017

Jul 31, 2019

SELL
$129.47 - $135.38 $20,715 - $21,660
-160 Reduced 0.35%
46,073 $5.99 Million
Q3 2017

Nov 30, 2017

SELL
$129.47 - $135.38 $49,975 - $52,256
-386 Reduced 0.83%
46,233 $6.01 Million
Q2 2017

Jul 31, 2019

SELL
N/A
-160 Reduced 0.34%
46,619 $6.17 Million
Q2 2017

Aug 08, 2017

BUY
N/A
46,779
46,779 $6.19 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sage Capital Advisors,Llc Portfolio

Follow Sage Capital Advisors,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Advisors,Llc with notifications on news.